New look at an old costimulator
Nature Immunology b, 231 - 232 (2005)

Peter S Linsley

Peter S. Linsley is with Rosetta Inpharmatics, A Wholly Owned Subsidiary of Merck & Co., Inc., Seattle, Washington 98109, USA.  peter_linsley@merck.com

The long-awaited structure of CD28 provides new understanding of its function and opens new avenues for probing this important costimulatory molecule.